Company intelligence / Profile preview

Double Wings Original Pharmaceutical

Beijing, Beijing, Chinashuangyi.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Double Wings Original Pharmaceutical is a China-based biopharmaceutical company focused on the discovery and development of innovative small molecule and biologic therapies. The company primarily targets oncology and inflammatory diseases, with a pipeline featuring multi-kinase inhibitors and recombinant human growth factors. Their lead programs include novel treatments for non-small cell lung cancer and chronic wound healing applications such as diabetic foot ulcers. Double Wings operates integrated R&D and manufacturing facilities to support its clinical-stage assets through the regulatory pathway in China.

Therapeutic areas: EndocrinologyOncologyDermatology
Modalities: Small moleculeRecombinant proteinBiologic
Industry: Biotech

Drug pipeline

1 asset

AOB01-0036

Beyond the preview

Go deeper on Double Wings Original Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double Wings Original Pharmaceutical.